Optimizing Treatment for Hypothyroidism
Thursday, April 10, 2025 | 19:00-20:30 ET | Virtual via Zoom
Thursday, April 10, 2025
19:00-20:30 ET
Virtual via Zoom
A portion of patients with hypothyroidism report experiencing residual symptoms that impact their quality of life while on standard-of-care levothyroxine monotherapy. This webinar will explore optimizing standard-of-care treatment and discuss ongoing management of hypothyroidism to enhance quality of life for patients.
Faculty

Mahua Ghosh
MBBS, PhD, FRCPC,
University of Alberta, Edmonton
(Chair & CSEM CPD Rep)

Deric Morrison
MD MHPE FRCPC,
Western University, London
(Speaker)

Ranjit Singarayer
MBChB, FRCPC, Cert. Endo.
LMC Diabetes & Endocrinology, London
(Speaker)
Learning Objectives
At the end of this symposium, participants will be able to:
- Identify when it is appropriate to start therapy for hypothyroidism.
- Optimize standard-of-care treatment for hypothyroidism.
- Understand that patients optimized on standard of care may still experience hypothyroid symptoms.
- Compare standard of care and alternative replacement strategies (T4 +/- T3) for patients who experience residual symptoms.
This learning activity was planned independently by CSEM to achieve scientific integrity, objectivity, and balance. CSEM received an unrestricted educational grant from Viatris for this activity.
Evaluation
Please complete an evaluation for the session in which you participated.
Your feedback is important.

Accreditation

The live activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Society of Endocrinology and Metabolism for a maximum of 2.0 hours.
Recorded sessions may be claimed as Section 2 Self-Learning credits:
Scanning – You may claim 0.5 Section 2 credits per recorded session.
Planned Learning – You may create a personal learning project to address a need, problem, issue/goal relevant to your professional practice, and claim 2 credits per hour.
Register Now
Mahua Ghosh
MBBS, PhD, FRCPC, is an Associate Professor in the Division of Endocrinology and Metabolism, Department of Medicine, at the University of Alberta, Edmonton. She serves as the Chair of the Canadian Society of Endocrinology and Metabolism Guidelines Committee.
Deric Morrison
I am an Associate Professor of Endocrinology and the Residency Program Director at Western University. I practice Endocrinology at St. Joseph’s Hospital in London. I am chair of Thyroid Cancer London and Endocrinology Thyroid Cancer Lead at St. Joseph’s Hospital (London).
Ranjit Singarayer
MBChB, FRCPC, Cert. Endo, is a community endocrinologist in London, ON. He completed his endocrinology training at Western University. He served as the chief endocrine resident and was the recipient of the Dr. Merrill Edmonds Outstanding Resident Award. He completed a one year clinical thyroid fellowship at the University of Toronto.
He has a strong clinical and personal interest in thyroid disease, both benign and malignant.